Why did the research institute apply for a patent for remdesivir in China?

Because in the face of the new coronavirus public health emergency, remdesivir developed by Gilead has always been expected to be a special drug against the new coronavirus.

For those who do scientific research, applying for a patent is the basic requirement for doing scientific research, and a scientific research will apply for a patent if it makes new achievements.

Research institutes say they have developed new uses for remdesivir, and there is evidence in experiments that it is effective in in vitro cell experiments, which is certainly something that no one else has done for the emerging novel coronavirus.

Therefore, research institutions can apply for the ownership of intellectual property rights. Of course, the scope of this patent is remdesivir's use against the novel coronavirus. <>

And the patent application is originally a "horse race".Whoever is ahead has the right to speak, and applying for a patent is also protecting their own interests。Although clinical trials are still underway, and the specific results have not yet been released, butRegardless of whether the test results prove that remdesivir is effective against the novel coronavirus, we will apply for this patent

Moreover, the practice of applying for patents is also to protect the interests of the state. If we don't preemptively register the use of the drug, the ** and ** of the drug may not be guaranteed in the future. In this way, China will inevitably be controlled by others, so foreign companies will give you medicine if they want to give you medicine, and if they don't want to give you medicine, they will not give you medicine, and they will want as much as they want.

Moreover, if China has a patent for remdesivir drug use, we can cross-license other patents with foreign companies, which is also a negotiation method.

The patent application is to prove that remdesivir is effective against the novel coronavirus in vitro cell experiments, and if you want to apply for a patent further, you must have clinical data, and you must also state that the drug cannot be used to make money.

For such an acute public health emergency, these drugs cannot be left unavailable to others, even if they are patented. If, after applying for a patent, the pharmaceutical company restricts the use of others during a public health emergency, there is an ethical problem.

Because the Chinese word Remesser Wechsler is only recognized in China, it is necessary to apply for a Chinese patent.

Because Chinese patents have become more and more numerous, and China's influence has been increasing, it is becoming more and more prominent in science and technology culture.

In response to this problem, my personal understanding is: this practice is to protect the interests of the country, if we do not preemptively register the use of the drug, in the future, China will be controlled by others, if we have a patent for the use of remdesivir, we can cross-license other patents with foreign companies, which is also a negotiation method.

China did not sell it.

Remdesivir, a Gilead Sciences drug candidate, is a nucleoside analogue with antiviral activity with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells and 30 nM for murine hepatitis virus in delayed brain tumor cells.

However, its effectiveness will need to be further verified by large-scale clinical trials. remdesivir (remdesivir) has not been approved for marketing in any country, and its safety and efficacy have not been proven. Remdesivir (remdesivir) is investigational and there are no data for 2019-ncov.

It is reported that the United States has discovered a drug called "remdesivir" that can be used for patients, which is a drug developed by American pharmaceutical giants, but has not been approved by the state for marketing, so there are no relevant listed companies at present.

In terms of clinical research, molecular synthesis, and raw materials in China, some listed companies have been cooperating with Gilead for a long time, and even directly participated in the listing of remdesivir.

Longyi Proton Co., Ltd. is a direct participant in the R&D and listing of remdesivir.

Gilead has always been one of Proton's three pillar customers, and its cooperation in China is indispensable for Proton's participation. Gilead - Proton - Yaoshi, Proton is the second largest customer of Yaoshi, and Yaoshi is an indirect beneficiary! Proton is a producer of intermediates, and the profit is not good, and the plant has been sold to medicine stones.

If the charging compartment of the Bluetooth headset is damaged, you need to call the official after-sales service of the brand manufacturer to explain the damage and ask if it can be repaired.

You can also bring the charging compartment and Bluetooth headset to the brand's official after-sales testing center, and after explaining the problems existing in the earphone charging compartment at the counter, ask the professional staff to judge whether the repair can be carried out and the cost of maintenance. If the earphones are still under warranty, you should choose an official after-sales channel for repair. If it is repaired through unofficial channels, the earbuds and charging case may not be covered by the warranty, and the cost of repair needs to be borne by yourself.

When buying headphones, choose regular brands of headphones as much as possible. Because of the regular headphone brand, in addition to quality assurance, you can also get official and regular after-sales support. When the earphones need to be repaired, it is necessary to choose official channels or regular maintenance channels to avoid new problems with the earphones caused by unofficial channels.

Maybe, maybe not. You can buy another unified model, the headphone compartment.

Bluetooth headset battery compartment is broken, you can't charge the earphone, as long as the earphone can be turned on and can be connected to the mobile phone, the phone will display the power of the earphone, the earphone is normal as long as you go to a battery compartment can be used.

As long as the phone can connect the Bluetooth headset, the battery will be displayed on the phone, but if you can't connect, then there is no way.

Yes, yes, it will be displayed as soon as it is charged.

Hydroxyl group, ester group, phosphate group attack, tetrahydro pat with furan ring?

Just two weeks ago, the European Commission officially approved the Redsia Commission as the drug for the new coronavirus, a decision that is undoubtedly correct in the face of the worsening global epidemic.

Because there is an urgent need for a drug to stabilize the affected population, so that they can see the hope of life, because the epidemic continues to worsen, there are more than 9 million cumulative confirmed people in the world, so it also makes the epidemic materials and basic equipment seriously warned, at this time a new crown miracle drug is needed to stabilize the overall situation, Remsivi, which has passed clinical trials, is undoubtedly the best representative, and now the vaccine is still in the research and development period, and it will be at least one to one and a half years to be put into the market. Although so many scientists have put a lot of effort into this, they still can't shorten the time for vaccine development, so they can only temporarily use remdesivir as a drug for the new coronavirus.

From the statement issued by the European Commission, it can be known that they believe that the approval of remdesivir as the first drug for the new crown virus is an important step in the fight against the new coronavirus. You must know that Rhett Siwei is definitely a peculiar presence in drugs, because it takes an average of 67 days for a new drug to be approved by the European Commission, but this drug was approved by the European Commission in just one week. This is the European Commission's response in exceptional circumstances.

The drug was developed by Gilead in the United States, and it is the only company in the world that can legally manufacture Remexyl. But the concern is that the U.S. ordered the company's products directly for the entire month of July, as well as 90% of the August and September production. This kind of behavior is not conducive to cutting off the opportunity for other countries to obtain the Remed-based committee, such a large-scale hoarding of goods is not only a disease and a compromise made by the United States in the case of the epidemic, but it also shows that the United States has always given priority to itself, this move must be worrying, so much so that Canada and other eight countries jointly signed an article demanding that when the vaccine is restricted, each country can get a fair opportunity to distribute vaccines.

It has to be said that the world can only be considered a real success if we get through this crisis together, and only one country has eliminated the epidemic does not mean that it is truly safe.

It's used all over the world, whether it's right or not, you don't count, let's do some personnel.

The European Union's official approval of remdesivir as a new crown ** drug is not the right decision. This is an important step in the fight against the coronavirus, yes, but the United States** has placed orders for the company's related products throughout July and 90% of its products in August and September, raising international concerns about the supply of remdesivir.

It was a bit impulsive to make this decision, and the drug remdesivir was approved in less than a month, and it was a bit unreasonable to use it before understanding its harm.

I don't think this decision is the right one, because remdesivir is not very effective and is not suitable for all patients.